Gerd Bouma

Gerd Bouma

Auto-generated profile, based on publicly available information

Gerd Bouma

VU University Medical Center

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2015 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlo CatassiCarlo Catassi
Carlo Catassi
Luca ElliLuca Elli
Luca Elli
BBBruno Bonaz
Bruno Bonaz
GBGerd Bouma
Gerd Bouma
ACAntonio Carroccio
Antonio Carroccio
Alessio FasanoAlessio Fasano
Alessio Fasano
Non-Celiac Gluten Sensitivity (NCGS) is a syndrome characterized by intestinal and extra-intestinal symptoms related to the ingestion of gluten-containing food, in subjects that are not affected by either celiac disease or wheat allergy. Given the lack of a NCGS biomarker, there is the need for standardizing the procedure leading to the diagnosis confirmation. In this paper we report experts’ recommendations on how the diagnostic protocol should be performed for the confirmation of NCGS. A full diagnostic procedure should assess the clinical response to the gluten-free diet (GFD) and measure the effect of a gluten challenge after a period of treatment with the GFD. The clinical evaluation is performed using a self-administered instrument incorporating a modified version of the Gastrointestinal Symptom Rating Scale. The patient identifies one to three main symptoms that are quantitatively assessed using a Numerical Rating Scale with a score ranging from 1 to 10. The double-blind placebo-controlled gluten challenge (8 g/day) includes a one-week challenge followed by a one-week washout of strict GFD and by the crossover to the second one-week challenge. The vehicle should contain cooked, homogeneously distributed gluten. At least a variation of 30% of one to three main symptoms between the gluten and the placebo challenge should be detected to discriminate a positive from a negative result. The guidelines provided in this paper will help the clinician to reach a firm and positive diagnosis of NCGS and facilitate the comparisons of different studies, if adopted internationally.

26 September 2013 in Nutrients
Verified
Journal Article
Open access
PDF file
CCCarlo Catassi
Carlo Catassi
JBJulio Cesar Bai
Julio Cesar Bai
BBBruno Bonaz
Bruno Bonaz
GBGerd Bouma
Gerd Bouma
ACAntonio Calabrò
Antonio Calabrò
Alessio FasanoAlessio Fasano
Alessio Fasano
Non Celiac Gluten sensitivity (NCGS) was originally described in the 1980s and recently a “re-discovered” disorder characterized by intestinal and extra-intestinal symptoms related to the ingestion of gluten-containing food, in subjects that are not affected with either celiac disease (CD) or wheat allergy (WA). Although NCGS frequency is still unclear, epidemiological data have been generated that can help establishing the magnitude of the problem. Clinical studies further defined the identity of NCGS and its implications in human disease. An overlap between the irritable bowel syndrome (IBS) and NCGS has been detected, requiring even more stringent diagnostic criteria. Several studies suggested a relationship between NCGS and neuropsychiatric disorders, particularly autism and schizophrenia. The first case reports of NCGS in children have been described. Lack of biomarkers is still a major limitation of clinical studies, making it difficult to differentiate NCGS from other gluten related disorders. Recent studies raised the possibility that, beside gluten, wheat amylase-trypsin inhibitors and low-fermentable, poorly-absorbed, short-chain carbohydrates can contribute to symptoms (at least those related to IBS) experienced by NCGS patients. In this paper we report the major advances and current trends on NCGS.

1 August 2014 in Gastroenterology
Verified
Journal Article
Open access
PDF file
NBNanne De Boer
Nanne De Boer
NGNicole M.F. van Gerven
Nicole M.F. van Gerven
AZAntonie Zwiers
Antonie Zwiers
BVBart J. Verwer
Bart J. Verwer
BHBart van Hoek
Bart van Hoek
GBGerd Bouma
Gerd Bouma
Autoimmune hepatitis (AIH) is an uncommon autoimmune liver disease of unknown etiology. We used a genome-wide approach to identify genetic variants that predispose individuals to AIH. We performed a genome-wide association study of 649 adults in The Netherlands with AIH type 1 and 13,436 controls. Initial associations were further analyzed in an independent replication panel comprising 451 patients with AIH type 1 in Germany and 4103 controls. We also performed an association analysis in the discovery cohort using imputed genotypes of the major histocompatibility complex region. We associated AIH with a variant in the major histocompatibility complex region at rs2187668 (P = 1.5 × 10−78). Analysis of this variant in the discovery cohort identified HLA-DRB1*0301 (P = 5.3 × 10−49) as a primary susceptibility genotype and HLA-DRB1*0401 (P = 2.8 × 10−18) as a secondary susceptibility genotype. We also associated AIH with variants of SH2B3 (rs3184504, 12q24; P = 7.7 × 10−8) and CARD10 (rs6000782, 22q13.1; P = 3.0 × 10−6). In addition, strong inflation of association signal was found with single-nucleotide polymorphisms associated with other immune-mediated diseases, including primary sclerosing cholangitis and primary biliary cirrhosis, but not with single-nucleotide polymorphisms associated with other genetic traits. In a genome-wide association study, we associated AIH type 1 with variants in the major histocompatibility complex region, and identified variants of SH2B3and CARD10 as likely risk factors. These findings support a complex genetic basis for AIH pathogenesis and indicate that part of the genetic susceptibility overlaps with that for other immune-mediated liver diseases.

21 November 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
Carlo CatassiCarlo Catassi
Carlo Catassi
Armin AlaediniArmin Alaedini
Armin Alaedini
CBChristian Bojarski
Christian Bojarski
BBBruno Bonaz
Bruno Bonaz
GBGerd Bouma
Gerd Bouma
DSDavid Sanders
David Sanders
Gluten-related disorders have recently been reclassified with an emerging scientific literature supporting the concept of non-celiac gluten sensitivity (NCGS). New research has specifically addressed prevalence, immune mechanisms, the recognition of non-immunoglobulin E (non-IgE) wheat allergy and overlap of NCGS with irritable bowel syndrome (IBS)-type symptoms. This review article will provide clinicians with an update that directly impacts on the management of a subgroup of their IBS patients whose symptoms are triggered by wheat ingestion.

8 November 2016 in Nutrients
Verified
Journal Article
Open access
PDF file
TGTom Van Gils
Tom Van Gils
PNPetula Nijeboer
Petula Nijeboer
CICatharina E. Ijssennagger
Catharina E. Ijssennagger
DSDavid Sanders
David Sanders
CMChris J. J. Mulder
Chris J. J. Mulder
GBGerd Bouma
Gerd Bouma
Background: A growing number of individuals reports symptoms related to the ingestion of gluten-containing food in the absence of celiac disease. Yet the actual prevalence is not well established. Methods: Between April 2015 and March 2016, unselected adults visiting marketplaces, dental practices and a university in The Netherlands were asked to complete a modified validated questionnaire for self-reported gluten sensitivity (srGS). Results: Among the 785 adults enquired, two had celiac disease. Forty-nine (6.2%) reported symptoms related to the ingestion of gluten-containing food. These individuals were younger, predominantly female and lived more frequently in urban regions compared with the other respondents. Symptoms reported included bloating (74%), abdominal discomfort (49%) and flatulence (47%). A total of 23 (47%) srGS individuals reported having had tried a gluten-free or gluten-restricted diet. Abdominal discomfort related to fermentable oligosaccharide, disaccharide, monosaccharide and polyol (FODMAP)-containing food was more often reported in srGS individuals compared with the other respondents (73.5% vs. 21.7%, p < 0.001). Conclusion: Self-reported GS is common in The Netherlands, especially in younger individuals, females and urban regions, although the prevalence was lower than in a comparable recent UK study. It cannot be excluded that FODMAPs are in part responsible for these symptoms.

31 October 2005 in International Journal of Immunogenetics
Verified
Journal Article
Closed access
PDF file
MBM. E. A. Borm
M. E. A. Borm
ABA. A. van Bodegraven
A. A. van Bodegraven
CMC. J. J. Mulder
C. J. J. Mulder
GKG. Kraal
G. Kraal
GBG. Bouma
G. Bouma